Skip to content
March 28, 2026
  • Centre Sanctions ₹700 Cr More for AIIMS Darbhanga Development
  • Global Study Flags High Maternal Mortality Burden in India in 2023
  • IMA Haryana Flags ₹400 Crore Ayushman Bharat Dues, Seeks CM’s Intervention
  • NMC Issues Advisory on Stem Cell Therapy Following Supreme Court Ruling
tishha_logo

Tishha News

  • Home
  • News
  • Economics
  • Technology Innovations
  • Global Healthcare
  • Expert Talks
  • Web Stories
  • Home
  • USFDA

USFDA

Indian MedTech
  • News

Indian MedTech Firms Eye US Market as China Loses Edge

tishha_newsApril 14, 2025April 14, 202506 mins

Indian MedTech manufacturers are spotting an opening to replace Chinese suppliers and expand their footprint in the lucrative US market….

Read More
Lupin
  • News

Lupin Secures USFDA Nod for Generic HIV Treatment Tablets

tishha_newsDecember 19, 2024December 19, 202403 mins

Lupin Limited a major global pharmaceutical announced on November 18th that it has received approval from the United States Food…

Read More
torent PHARMA
  • News
  • Technology Innovations

“Torrent Pharma Takes Proactive Steps to Address USFDA Observation, Ensuring Excellence and Continued Growth in Global Markets”

tishha_newsSeptember 26, 2024September 26, 202409 mins

Torrent Pharma one of India’s leading pharmaceutical companies, has received an observation from the U.S. Food and Drug Administration (USFDA)…

Read More
fda
  • Global Healthcare
  • News

Breakthrough: FDA Greenlights Rapid Hepatitis C Test for Immediate Point-of-Care Diagnosis

tishha_newsJune 28, 2024June 28, 2024010 mins

Today, the U.S. Food and Drug Administration (FDA) granted marketing authorization to Cepheid for the Xpert HCV test and GeneXpert…

Read More
RSV
  • Global Healthcare
  • News

US Health Officials Amplify Endorsement of RSV Shots for Elders

tishha_newsJune 27, 2024June 27, 202406 mins

On Wednesday, U.S. health officials reinforced their endorsement of respiratory syncytial virus (RSV) vaccinations, especially targeting Americans aged 75 and…

Read More
Cipla_Secures_Final_USFDA_Approval_for_Lanreotide_Injection
  • Articles
  • Global Healthcare

Cipla Secures Final USFDA Approval for Lanreotide Injection: A Major Step Forward in Treating Hormonal Tumors

tishha_newsMay 25, 2024June 3, 202407 mins

Cipla, a global pharmaceutical leader, has recently announced a significant milestone in its mission to provide advanced treatments for hormonal…

Read More

Most Viewed

News
Centre Sanctions ₹700 Cr More for AIIMS Darbhanga Development
The Central Government has approved an additional ₹700 crore for…
News
Global Study Flags High Maternal Mortality Burden in India in 2023
A global analysis published in The Lancet Obstetrics, Gynaecology and…

Random

1

Centre Sanctions ₹700 Cr More for AIIMS Darbhanga Development

  • News
2

Global Study Flags High Maternal Mortality Burden in India in 2023

  • News
3

IMA Haryana Flags ₹400 Crore Ayushman Bharat Dues, Seeks CM’s Intervention

  • News
4

NMC Issues Advisory on Stem Cell Therapy Following Supreme Court Ruling

  • News
5

Dr Sangita Reddy Appointed NATHEALTH President for FY 2026-27

  • News
6

India’s Health Insurance Premiums Cross ₹1.2 Lakh Crore in FY 2024-25

  • News
7

IIT Bombay Develops DNA-Based Approach to Combat Antibiotic Resistance

  • News
8

Haryana Rolls out AI-powered X-ray Devices in 2,111 Villages to Boost Early TB Detection

  • News
tishha_logo
TISHHA News Developed By BlazeThemes.